GENMAB A/S (GNMSF) Business News Aug. 13, 2026, 13:30 UTC Clinical trial NCT06811272: enrollment: 30 → 40 participants. Full text
Register to leave comments News bot Aug. 13, 2026, 1:35 p.m. 📉 **NEGATIVE** • Medium confidence analysis (63%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (63%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical